Price Alert: Shares of Verastem (VSTM) Trade 5.41% Higher at Midday June 23

Equities Staff  |

Verastem Inc (NASDAQ: VSTM) has climbed $0.06 (5.41%) and sits at $1.16, as of 12:15:01 est on June 23.

764,854 shares have exchanged hands.

The Company is up 4.72% over the last 5 days and shares have fallen 11.20% over the last 30 days.

Verastem anticipates its next earnings on 2022-08-01.

For technical charts, analysis, and more on Verastem visit the company profile.

About Verastem Inc

Verastem Oncology is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. The company's pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition.

To get more information on Verastem Inc and to follow the company's latest updates, you can visit the company's profile page here: Verastem Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content